Cargando…
Evaluation of endothelial cell-specific molecule-1 as a biomarker of glycocalyx damage in canine myxomatous mitral valve disease
BACKGROUND: Endothelial cell-specific molecule-1 (ESM-1) has emerged as a potential biomarker for cardiovascular disease in humans. Myxomatous mitral valve disease (MMVD) is the most common heart disease in dogs, and we hypothesized that MMVD causes chronic inflammation that increases susceptibility...
Autores principales: | Hong, Hee-Jeong, Oh, Ye-In, Park, Su-Min, An, Ju-Hyun, Kim, Tae-Hee, Chae, Hyung-Kyu, Seo, Kyoung-won, Youn, Hwa-Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254417/ https://www.ncbi.nlm.nih.gov/pubmed/35790968 http://dx.doi.org/10.1186/s12917-022-03344-y |
Ejemplares similares
-
Circulating hyaluronan as a marker of endothelial glycocalyx damage in dogs with myxomatous mitral valve disease and dogs in a hypercoagulable state
por: Lawrence-Mills, Sara J., et al.
Publicado: (2022) -
Myxomatous degeneration of the mitral valve
por: Neto, Felippe Lazar, et al.
Publicado: (2018) -
Review of Diagnostic and Therapeutic Approach to Canine Myxomatous Mitral Valve Disease
por: Menciotti, Giulio, et al.
Publicado: (2017) -
Expression Profiling of Circulating MicroRNAs in Canine Myxomatous Mitral Valve Disease
por: Li, Qinghong, et al.
Publicado: (2015) -
Evaluation of canine 2D cell cultures as models of myxomatous mitral valve degeneration
por: Tan, Karen, et al.
Publicado: (2019)